The Latest Cardiac and Vascular News
VALHALLA, N.Y., July 16, 2021 /PRNewswire/ — Retia Medical announced today the publication of a new study that further confirms the superior accuracy of its Multi-Beat Analysis (MBA™) algorithm in comparison to a competing option. The study, published on July 10th in BMC Anesthesiology (https://bmcanesthesiol.biomedcentral.com/track/pdf/10.1186/s12871-021-01415-5.pdf) compared the accuracy of two cardiac output monitors, the […]
GETINGE, Sweden, July 16, 2021 /PRNewswire/ — “In total, sales increased by 3.6% organically compared with the second quarter 2020, and the order intake declined by 6.1% organically compared with 2020 when we received very large orders of advanced ICU ventilators”, says Mattias Perjos, President & CEO. “Cash flow remained strong and net debt […]
The collaboration breaks new ground by integrating Canon’s AI-powered CT technology with Cleerly’s digital pathway solution for analysis of coronary artery disease. TUSTIN, Calif.–(BUSINESS WIRE)–Canon Medical Systems, USA joins forces with Cleerly in a strategic partnership to support simple and streamlined adoption of cardiac CT and create a new standard […]
Elucid Founder, Andrew Buckler, To Present Findings at the SCCT Annual Scientific Meeting BOSTON–(BUSINESS WIRE)–Elucid, a medical technology company developing AI software for physicians to optimize the treatment of patients with known or suspected vascular disease, announced today that its founder Andrew Buckler will present findings from two separate studies […]
Amy Burroughs and Dr. Charles Semba Bring Extensive and Complementary Experience in Building Specialty Therapeutics Companies MINNEAPOLIS–(BUSINESS WIRE)–DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, announced today the election of two industry veterans to the Company’s Board of […]
Investigational PerQseal Blue designed to be the world’s first and only fully absorbable device for large-bore venous closure Development program funded by €2.5 million grant awarded by the European Innovation Council Accelerator GALWAY, Ireland–(BUSINESS WIRE)–Vivasure Medical®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced its development […]
ENGLEWOOD, Colo., July 15, 2021 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders and an increased Adjusted EBITDA estimate for Q2 2021. Thomas Sandgaard, CEO of Zynex said: “Our […]
SAN CARLOS, Calif., July 15, 2021 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a company focused on cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases today announces that the Japan Patent Office has granted Patent No: 6887216 titled, “Target Site Selection, Entry, and Update With Automatic Remote Image […]
CARLSBAD, Calif., July 14, 2021 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (Nasdaq: AFIB) (“Acutus”) today announced the pricing of its underwritten public offering of 5,500,000 shares of its common stock at a price to the public of $14.00 per share. All of the shares of common stock are being offered […]
Transforming the way heart disease is diagnosed and treated, HeartFlow’s artificial intelligence-enabled software platform brings precision heart care to cardiology. The HeartFlow Analysis is the first and only non-invasive tool to assist with the diagnosis, management and treatment of patients with heart disease, the most common type of cardiovascular disease […]
